CTLA4 and neoplasm: The expression of several lymphocyte signaling molecules, including CTLA4, LAT, PDCD1, and ZAP70, was maintained in the transition from human tumor to CX, and was particularly prominent in the CXs derived from D61540 (Figure 6).